Enlicitide Decanoate: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

7

US states with sites

18

Countries

Phase breakdown

Phase 2 1 Phase 3 1

Conditions being studied

Condition	Trials
Heterozygous Familial Hypercholesterolemia (HeFH)	1
High cholesterol	1

Recruiting trials involving Enlicitide Decanoate

A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)
NCT07058077 · Phase: Phase 2, Phase 3 · Ages: 6 Years to 17 Years · Sex: All (male and female) · 43 locations

Common questions

How many recruiting trials involve Enlicitide Decanoate?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.